Comment on: Osteopontin as toxic marker [1]

Radiotherapy and Oncology

Volumn 78, Issue 2, 2006, Pages 230-

  Le, Quynh Thu ^a   Cao, Hongbin ^a   Koong, Albert ^a   Giaccia, Amato ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; OSTEOPONTIN; TOXIN;

CELL CULTURE; CELL PROLIFERATION; CELL TYPE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOXIA; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REOXYGENATION; TUMOR CELL;

CELL COUNT; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; OSTEOPONTIN; PHOSPHOPROTEINS; SIALOGLYCOPROTEINS;

EID: 33644752841     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.12.011     Document Type: Letter

References (3)

1. H.M. Said, A. Katzer, M. Flentje, and D. Vordermark Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells Radiother Oncol 76 2005 200 205
2. Q.T. Le, P.D. Sutphin, and S. Raychaudhuri Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Clin Cancer Res 9 2003 59 67
3. Y. Zhu, D.T. Denhardt, and H. Cao Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer Oncogene 2005